← Open Payments lookup

MARIA LOERA-QUINTANILLA: Open Payments

NPI 1124295035 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,420 in 75 payments from 10 companies in 2025. Trend: 2023 $798 · 2024 $817 · 2025 $1,420

Food & beverage: $1,420
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.27$456
Alkermes, Inc.14$310
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)12$227
Lundbeck LLC6$111
Neurocrine BioSciences, Inc.6$111
Janssen Pharmaceuticals, Inc3$71
Otsuka America Pharmaceutical, Inc.3$58
ABBVIE INC.2$47
Galderma Laboratories, L.P.1$15
E.R. Squibb & Sons, L.L.C.1$14

Products named: UZEDY, CAPLYTA, ABILIFY ASIMTUFII, ARISTADA, AUSTEDO XR, LYBALVI, INGREZZA, INVEGA SUSTENNA.

Industry payments across TX — which companies pay providers there.